Godavari Drugs
124.65
+2.65(+2.17%)
Market Cap₹126.28 Cr
PE Ratio30.20
IndustryHealthcare
Company Performance:
1D+2.17%
1M-1.66%
6M+51.18%
1Y+32.20%
5Y+105.69%
View Company Insightsright
More news about Godavari Drugs
11Feb 26
Godavari Drugs Reports Q3FY26 Results, Approves ₹5.50 Crore Working Capital Loan
Godavari Drugs reported Q3FY26 net profit of ₹75.76 lakhs on revenue of ₹2218.43 lakhs, showing decline from previous year's ₹76.74 lakhs profit and ₹2955.21 lakhs revenue. Nine-month performance also declined with net profit at ₹279.84 lakhs versus ₹348.69 lakhs last year. The Board approved a ₹5.50 crore short-term working capital loan from ICICI Bank with 6-month tenure for new order execution requirements.
 no imag found
15Jan 26
Godavari Drugs Board Approves Preferential Issue of Convertible Warrants and Equity Shares Worth ₹44.12 Crores
Godavari Drugs Limited board approved preferential issue of 23,60,065 convertible warrants and 25,96,935 equity shares at ₹89 each, raising approximately ₹44.12 crores. The warrants are exclusively for 9 promoters with 18-month conversion period, while equity shares target 31 investors including promoters and non-promoters. Post-allotment shareholding will be 51.52% promoters and 48.48% public, subject to shareholder approval in EGM scheduled February 12, 2026.
 no imag found
08Jan 26
Godavari Drugs Limited Issues Clarification on Share Price Movement to BSE
Godavari Drugs Limited submitted a clarification to BSE on January 8, 2026, regarding significant share price movement, confirming no unpublished price sensitive information exists. The company attributed the price volatility to market-driven demand-supply factors and reaffirmed its commitment to regulatory compliance under SEBI regulations.
 no imag found
Godavari Drugs
124.65
+2.65
(+2.17%)
1 Year Returns:+32.20%
Industry Peers
Sun Pharmaceutical
1,874.40
(+0.34%)
Divis Laboratories
6,753.50
(+0.10%)
Torrent Pharmaceuticals
4,504.40
(-0.21%)
Cipla
1,437.90
(+0.33%)
Dr Reddys Laboratories
1,328.40
(+2.08%)
Zydus Life Science
1,099.30
(-1.16%)
Lupin
2,367.60
(+0.42%)
Mankind Pharma
2,483.00
(-1.80%)
Aurobindo Pharma
1,530.60
(-0.23%)
Laurus Labs
1,454.20
(-1.81%)